Opendata, web and dolomites

AutoCapSyn SIGNED

Capsule based machines for the automated synthesis of organic molecules for drug discovery and medicinal chemistry

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AutoCapSyn project word cloud

Explore the words cloud of the AutoCapSyn project. It provides you a very rough idea of what is the project "AutoCapSyn" about.

candidate    exposure    route    innovative    compatibility    leader    expensive    declining    toxic    capsule    first    introduces    feasible    environmentally    amount    benchtop    unfriendly    purification    biological    enclosed    drug    machines    chain    delays    trained    customer    consuming    discovery    prepare    automated    successful    commercial    completion    synthesises    efficient    agents    chemical    touch    components    offers    form    protocols    safer    reaction    dynamics    specialists    machine    capsules    market    synple    channels    critical    supply    continues    size    safe    optimal    pricing    exploration    commercially    safety    lower    benefits    deeper    feasibility    gaining    structure    data    timesaving    button    technically    molecules    minimised    rely    scaffolds    goals    productivity    synthesis    robustness    aid    launch    marketing    unsafe    unpredictable    sales    frequency    flow    tiny    ing    ultimately    time    appropriate    simplify    countries    amounts    environment    flexibility    minus   

Project "AutoCapSyn" data sheet

The following table provides information about the project.

Coordinator
SYNPLE CHEM AG 

Organization address
address: VLADIMIR-PRELOG-WEG 3, HCI F314
city: ZURICH
postcode: 8093
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYNPLE CHEM AG CH (ZURICH) coordinator 50˙000.00

Map

 Project objective

Drug discovery continues to rely on the synthesis of tiny amounts of candidate molecules using unpredictable protocols that require highly trained specialists. As such, it remains expensive, time-consuming, unsafe, and environmentally unfriendly. Declining productivity, high costs, and safety issues, have driven a large amount of chemical synthesis to lower cost countries, which introduces delays and uncertainty in the drug discovery process, where the flexibility to rapidly prepare new molecules in response to biological data is critical to success.

In order to address these problems, Synple has developed an innovative, benchtop, capsule-based machine that synthesises new molecules at the touch of a button. This fully automated technology offers significant timesaving and productivity benefits. With all necessary components for the safe execution of the reaction and purification of the resulting products enclosed within the capsule, the user’s exposure to toxic agents will be minimised. Use of the automated machines with the innovative capsules will aid chemical research organisations as they can greatly simplify the way in which key chemical scaffolds are produced while providing a safer and more efficient work environment.

The first goal of this feasibility study is to determine if the technology is technically feasible in its current form (robustness and compatibility with customer’s current work flow). The second goal – exploration of the commercially feasibility − will be achieved by gaining a deeper insight in the market size and dynamics, as well as determining frequency of use. Upon successful completion of these goals, we aim to then establish the steps required for commercial launch. Key parameters include: defining the supply chain and pricing structure and identifying the most appropriate sales, marketing and distribution channels. Ultimately, Synple aims to use this feasibility study to identify the optimal route to becoming the market leader.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AUTOCAPSYN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AUTOCAPSYN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More